Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBTW), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
The CLBTW news page on Stock Titan aggregates coverage related to Cellebrite DI Ltd., the underlying company for the CLBTW warrants. Cellebrite’s ordinary shares trade on Nasdaq under the symbol CLBT, and the company regularly issues press releases that are furnished to the SEC on Form 6-K. These announcements provide insight into its digital investigation and intelligence business, financial performance and strategic initiatives.
Readers can expect news about Cellebrite’s AI-powered Digital Investigation Platform, which the company says enables customers to lawfully access, collect, analyze and share digital evidence in legally sanctioned investigations while preserving data privacy. Coverage often highlights how thousands of public safety organizations, intelligence agencies and businesses use its digital forensic and investigative solutions across cloud, on-premises and hybrid deployments.
Company updates frequently include quarterly financial results, commentary on annual recurring revenue and subscription trends, and discussions of non-GAAP metrics and key performance indicators. Other news items describe product and platform developments, such as enhancements to its Guardian suite, Inseyets digital forensics software, Pathfinder investigative analytics and the Cellebrite Government Cloud, which is progressing through the FedRAMP process with U.S. Department of Justice sponsorship.
Strategic announcements have also covered the agreement to acquire, and subsequent completion of the acquisition of, Corellium, a provider of Arm-based virtualization software, along with integrations that expand mobile virtualization and device analysis capabilities. Additional stories highlight partnerships and initiatives like the integration of NCMEC’s CyberTipline hash value list into Inseyets to support child exploitation investigations, as well as events such as the C2C User Summit and Digital Justice Awards.
By following CLBTW-related news, investors and observers gain context on Cellebrite’s operational focus, technology roadmap, governance developments and regulatory milestones that may be relevant when evaluating the warrants linked to CLBT.
Cellebrite, a leader in digital investigative solutions, announced the availability of its Endpoint Inspector SaaS on the AWS Marketplace. This solution, part of Cellebrite's Case-to-Closure platform, allows corporate investigators and eDiscovery practitioners to collect and analyze data in real-time from various remote devices. Utilizing AWS cloud infrastructure, Endpoint Inspector SaaS enhances data extraction speed and insight depth for corporate investigations, such as fraud and intellectual property theft. It supports hybrid work environments, enabling secure, consent-based data collection without the need for physical device access. AWS Marketplace facilitates easy deployment, automated billing, and payment tracking.
Cellebrite (NASDAQ: CLBT) announced its Q1 2024 results, reporting a 27% year-over-year increase in Annual Recurring Revenue (ARR) to $331.8 million. Q1 2024 revenue rose by 26% to $89.6 million, driven by a 29% growth in subscription revenue. The company recorded a GAAP net loss of $71.4 million and a non-GAAP net income of $16.9 million. Adjusted EBITDA stood at $17.6 million with a 19.7% margin. CEO Yossi Carmil emphasized the global expansion and profitability improvements, noting the positive reception of new products like the Inseyets digital forensics software. The company reaffirmed its outlook for 2024, expecting ARR between $380 million and $400 million, and revenue between $370 million and $380 million for the full year.
Cellebrite (NASDAQ: CLBT), a global leader in digital investigative solutions, announced its participation in several investor conferences from May 26 to June 5, 2024. The company will engage in various formats, including fireside chats, 1x1 meetings, and presentations.
Key dates include May 26 at the Oppenheimer 25th Annual Israeli Conference, May 29 at the Craig-Hallum Institutional Investor Conference, May 30 at the TD Cowen 52nd Annual Technology, Media & Telecom Conference, and June 5 at the William Blair 44th Annual Growth Stock Conference.
Cellebrite executives like Dana Gerner (CFO), Andrew Kramer (VP), and Yossi Carmil (CEO) will present at these events. The conferences are opportunities for the company to highlight its digital investigative solutions and connect with investors.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.